tyrosine has been researched along with Cardiomyopathy, Hypertrophic in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayati, M; Bermea, KC; Everett, AD; Foster, DB; Fu, Z; Gabrielson, K; Heravi, A; Kim, HB; Medina, A; Murphy, AM; Na, CH; Paolocci, N; Ramirez-Correa, GA; Xu, M; Yang, X; Zhang, X | 1 |
| Bennett, AM; Enyenihi, L; Perla, S; Yi, JS | 1 |
| Asselbergs, FW; Carrier, L; Dalinghaus, M; Dorsch, LM; Dos Remedios, C; Harakalova, M; Jimenez, CR; Knol, JC; Kuster, DWD; Michels, M; Mokry, M; Moutin, MJ; Pei, J; Pham, TV; Piersma, SR; Schelfhorst, T; Schlossarek, S; Schuldt, M; van der Velden, J | 1 |
| Bhat, RV; Chua, J; Fritsche-Danielson, R; Gan, LM; Hausenloy, DJ; Hernandez-Resendiz, S; Jonsson, MKB; Knöll, R; Kp, MMJ; Liehn, EA; Lin, YH; Michaëlsson, E; Ramachandra, CJA; Ryden-Markinhuhta, K; Sadayappan, S; Shim, W; Tang, HC; Wong, P | 1 |
| Doh, CY; Li, J; Mamidi, R; Stelzer, JE | 1 |
| André, N; Jubin, V; Ovaert, C; Roquelaure, B | 1 |
| Bercovici, J; Moalic, JM; Swynghedauw, B | 1 |
| Healy, JM; Keating, KE; Krivosic, I; Krivosic-Horber, R; Lunardi, J; Manning, BM; McCarthy, TV; Monnier, N; Quane, KA | 1 |
| Akanuma, M; Harada, H; Hiroi, S; Katsushika, S; Kimura, A; Nakamura, H; Ohsuzu, F; Satoh, M | 1 |
| Colli, A; Edwards, MA; Green, A; Rylance, G | 1 |
10 other study(ies) available for tyrosine and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy.
Topics: Animals; Cardiomegaly; Cardiomyopathy, Hypertrophic; Mice; Phosphorylation; Proteome; Serine; Threonine; Tyrosine | 2022 |
Tyrosyl phosphorylation of PZR promotes hypertrophic cardiomyopathy in PTPN11-associated Noonan syndrome with multiple lentigines.
Topics: Animals; Cardiomyopathy, Hypertrophic; Disease Models, Animal; Female; Intracellular Signaling Peptides and Proteins; LEOPARD Syndrome; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Myocytes, Cardiac; Phosphoproteins; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Tyrosine | 2020 |
Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy.
Topics: Adult; Aged; Animals; Cardiac Myosins; Cardiomyopathy, Hypertrophic; Carrier Proteins; Case-Control Studies; Disease Models, Animal; Female; Haploinsufficiency; Humans; Male; Middle Aged; Myosin Heavy Chains; Proteomics; Sarcomeres; Troponin I; Troponin T; Tubulin; Tyrosine; Ventricular Outflow Obstruction; Ventricular Septum | 2021 |
Inhibiting cardiac myeloperoxidase alleviates the relaxation defect in hypertrophic cardiomyocytes.
Topics: Animals; Cardiac Myosins; Cardiomyopathy, Hypertrophic; Carrier Proteins; Cell Line; Disease Models, Animal; Enzyme Inhibitors; Humans; Hypertrophy, Left Ventricular; Induced Pluripotent Stem Cells; Male; Mice, Inbred C57BL; Mutation, Missense; Myocardial Contraction; Myocytes, Cardiac; Myosin Heavy Chains; Peroxidase; Phosphorylation; Reactive Oxygen Species; Tyrosine; Ventricular Function, Left | 2022 |
The HCM-causing Y235S cMyBPC mutation accelerates contractile function by altering C1 domain structure.
Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Cardiomyopathy, Hypertrophic; Carrier Proteins; Male; Mice; Mice, 129 Strain; Mice, Knockout; Mutant Proteins; Mutation, Missense; Myocardial Contraction; Myocardium; Protein Domains; Sarcomeres; Serine; Tyrosine | 2019 |
Successful treatment of severe cardiomyopathy with NTBC in a child with tyrosinaemia type I.
Topics: Amino Acid Metabolism, Inborn Errors; Cardiomyopathy, Hypertrophic; Cyclohexanones; Echocardiography; Enzyme Inhibitors; Humans; Hypertrophy, Left Ventricular; Infant; Male; Nitrobenzoates; Tyrosine; Tyrosinemias | 2005 |
Myosin heavy chain and actin fractional rates of synthesis in normal and overload rat heart ventricles.
Topics: Actins; Animals; Cardiomyopathy, Hypertrophic; Heart Ventricles; Male; Myofibrils; Myosins; Rats; Rats, Inbred Strains; Tyrosine | 1984 |
Mutation screening of the RYR1 gene in malignant hyperthermia: detection of a novel Tyr to Ser mutation in a pedigree with associated central cores.
Topics: Amino Acid Sequence; Base Sequence; Calcium Channels; Cardiomyopathy, Hypertrophic; Chromosomes, Human, Pair 19; DNA Mutational Analysis; Female; Genes; Genetic Linkage; Genetic Predisposition to Disease; Genetic Testing; Humans; Male; Malignant Hyperthermia; Molecular Sequence Data; Muscle Proteins; Myopathies, Nemaline; Pedigree; Point Mutation; Polymorphism, Single-Stranded Conformational; Ryanodine Receptor Calcium Release Channel; Serine; Tyrosine | 1994 |
Hypertrophic obstructive cardiomyopathy due to a novel T-to-A transition at codon 624 in the beta-myosin heavy chain (beta-MHC) gene possibly related to the sudden death.
Topics: Amyl Nitrite; Asparagine; Aspirin; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Codon; Death, Sudden, Cardiac; Echocardiography, Doppler; Electrocardiography; Female; Heart Septum; Humans; Middle Aged; Mitral Valve; Myosin Heavy Chains; Point Mutation; Tyrosine | 1997 |
Tyrosinaemia type I and hypertrophic obstructive cardiomyopathy.
Topics: Amino Acid Metabolism, Inborn Errors; Cardiomyopathy, Hypertrophic; Child, Preschool; Humans; Infant; Tyrosine | 1987 |